Mettler-Toledo International Inc. (NYSE:MTD) Position Reduced by Brown Lisle Cummings Inc.

Brown Lisle Cummings Inc. reduced its position in Mettler-Toledo International Inc. (NYSE:MTD) by 8.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 695 shares of the medical instruments supplier’s stock after selling 65 shares during the period. Brown Lisle Cummings Inc.’s holdings in Mettler-Toledo International were worth $850,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Blue Trust Inc. grew its holdings in shares of Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 17 shares in the last quarter. Ashton Thomas Securities LLC purchased a new position in Mettler-Toledo International during the 3rd quarter valued at about $37,000. Sound Income Strategies LLC increased its holdings in shares of Mettler-Toledo International by 4,500.0% in the 4th quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock valued at $56,000 after purchasing an additional 45 shares during the period. Raleigh Capital Management Inc. lifted its position in shares of Mettler-Toledo International by 272.7% in the third quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 30 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Mettler-Toledo International by 60.0% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier’s stock worth $72,000 after purchasing an additional 18 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Down 1.5 %

NYSE:MTD opened at $1,343.97 on Tuesday. The company’s 50 day moving average is $1,267.00 and its 200-day moving average is $1,343.14. Mettler-Toledo International Inc. has a 12 month low of $1,133.46 and a 12 month high of $1,546.93. The firm has a market cap of $28.36 billion, a price-to-earnings ratio of 36.24, a P/E/G ratio of 4.83 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The business had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. Research analysts predict that Mettler-Toledo International Inc. will post 40.42 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

MTD has been the subject of a number of research analyst reports. Wells Fargo & Company cut their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their price objective for the stock from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Stifel Nicolaus lowered their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Evercore ISI raised Mettler-Toledo International from an “in-line” rating to an “outperform” rating and raised their price target for the stock from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. Finally, Wolfe Research assumed coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $1,351.25.

Insider Transactions at Mettler-Toledo International

In other news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now owns 240 shares in the company, valued at approximately $314,820. The trade was a 24.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Gerry Keller sold 140 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the sale, the insider now owns 6 shares of the company’s stock, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.